Paper36979300
Oxidative Stress Biomarkers among Schizophrenia Inpatients.
Więdłocha M and 8 others. Brain Sci, 2023. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Oxidative Stress Biomarkers among Schizophrenia Inpatients. Papers, record 36979300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979300
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15099610 | The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. | Schizophr Res | 2004 | https://conductscience.org/library/papers/15099610 | PubMed |
| 2 | 21392552 | Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. | Prog Neuropsychopharmacol Biol Psychiatry | 2011 | https://conductscience.org/library/papers/21392552 | PubMed |
| 3 | 31885792 | Salivary Antioxidant Barrier, Redox Status, and Oxidative Damage to Proteins and Lipids in Healthy Children, Adults, and the Elderly. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31885792 | PubMed |
| 4 | 18398470 | Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. | PLoS One | 2008 | https://conductscience.org/library/papers/18398470 | PubMed |
| 5 | 6727660 | Catalase in vitro. | Methods Enzymol | 1984 | https://conductscience.org/library/papers/6727660 | PubMed |
| 6 | 24894883 | Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia. | Schizophr Bull | 2015 | https://conductscience.org/library/papers/24894883 | PubMed |
| 7 | 19742187 | A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia. | Indian J Psychiatry | 2008 | https://conductscience.org/library/papers/19742187 | PubMed |
| 8 | 29499967 | TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. | Schizophr Res | 2018 | https://conductscience.org/library/papers/29499967 | PubMed |
| 9 | 2278986 | A depression rating scale for schizophrenics. | Schizophr Res | 1990 | https://conductscience.org/library/papers/2278986 | PubMed |
| 10 | 19788631 | Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. | Psychiatry Clin Neurosci | 2009 | https://conductscience.org/library/papers/19788631 | PubMed |
| 11 | 23657077 | Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. | Prog Neuropsychopharmacol Biol Psychiatry | 2013 | https://conductscience.org/library/papers/23657077 | PubMed |
| 12 | 15341194 | Nitric oxide as a physiopathological factor in neuropsychiatric disorders. | In Vivo | 2004 | https://conductscience.org/library/papers/15341194 | PubMed |
| 13 | 21068826 | Rethinking schizophrenia. | Nature | 2010 | https://conductscience.org/library/papers/21068826 | PubMed |
| 14 | 672633 | Microsomal lipid peroxidation. | Methods Enzymol | 1978 | https://conductscience.org/library/papers/672633 | PubMed |
| 15 | 19139851 | Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. | Psychopharmacology (Berl) | 2009 | https://conductscience.org/library/papers/19139851 | PubMed |
| 16 | 9690328 | Reduced status of plasma total antioxidant capacity in schizophrenia. | Schizophr Res | 1998 | https://conductscience.org/library/papers/9690328 | PubMed |
| 17 | 20017110 | BDNF function and intracellular signaling in neurons. | Histol Histopathol | 2010 | https://conductscience.org/library/papers/20017110 | PubMed |
| 18 | 12640213 | The effect of risperidone treatment on superoxide dismutase in schizophrenia. | J Clin Psychopharmacol | 2003 | https://conductscience.org/library/papers/12640213 | PubMed |
| 19 | 15939978 | Oxidative stress during treatment with first- and second-generation antipsychotics. | J Neuropsychiatry Clin Neurosci | 2005 | https://conductscience.org/library/papers/15939978 | PubMed |
| 20 | 8782590 | Quantitation of nitrate and nitrite in extracellular fluids. | Methods Enzymol | 1996 | https://conductscience.org/library/papers/8782590 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42615015 | From Micro Molecular to Functional Levels Through Macro Structures: Mediation of Structural Brain Changes on the Relationship Between Oxidative Stress and Cognition in Early Onset Psychosis. | Schizophr Bull Open | 2026 | https://conductscience.org/library/papers/42615015 | PubMed |
| 42459281 | Association of oxidative stress, metacognition, and psychopathology in patients with schizophrenia: a case-control study. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42459281 | PubMed |
| 42439630 | Redox-Mitochondria-Immune Network Dysregulation in Schizophrenia: From Selective Cellular Vulnerability to Circuit Dysfunction. | Cells | 2026 | https://conductscience.org/library/papers/42439630 | PubMed |
| 42114333 | Protein glycoxidation in neuropsychiatric disorders-from basic research to clinical practice. | Redox Biol | 2026 | https://conductscience.org/library/papers/42114333 | PubMed |
| 41951663 | Upregulation of DNA repair-related genes in the prefrontal cortex of patients with schizophrenia with low genetic risk. | Schizophrenia (Heidelb) | 2026 | https://conductscience.org/library/papers/41951663 | PubMed |
| 41945311 | Glutathione deficiency in the early postnatal developmental period as a neurodevelopmental animal model of schizophrenia. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/41945311 | PubMed |
| 41750566 | Plasma, Urinary, and Salivary Total Redox Status in Critically Ill Patients with Brain Injury and Secondary Organ Failure. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41750566 | PubMed |
| 41163275 | Schizophrenia Pathophysiology: Neurotransmitter Dysfunctions and Biomarker Frontiers. | Curr Top Med Chem | 2026 | https://conductscience.org/library/papers/41163275 | PubMed |
| 41037227 | Can Oxidative Stress Biomarkers Differentiate Trichotillomania from Obsessive-Compulsive Disorder and Healthy Controls? | J Mol Neurosci | 2025 | https://conductscience.org/library/papers/41037227 | PubMed |
| 41022854 | The shared genetic architecture between schizophrenia and common peripheral organ imaging phenotypes. | Schizophrenia (Heidelb) | 2025 | https://conductscience.org/library/papers/41022854 | PubMed |
| 40806624 | The Redox Revolution in Brain Medicine: Targeting Oxidative Stress with AI, Multi-Omics and Mitochondrial Therapies for the Precision Eradication of Neurodegeneration. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806624 | PubMed |
| 40630169 | Case Report: Remission of schizophrenia using a carnivore ketogenic metabolic therapy with nutritional therapy practitioner support. | Front Nutr | 2025 | https://conductscience.org/library/papers/40630169 | PubMed |
| 40618201 | Aging in Schizophrenia: Perspectives on Molecular Mechanisms and a Mini-review. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/40618201 | PubMed |
| 40608148 | Inhibition of oxidative stress, neuroinflammatory cytokines, and protein expressions contributes to the antipsychotic effects of geraniol in mice with ketamine-induced schizophrenia. | J Neuroimmune Pharmacol | 2025 | https://conductscience.org/library/papers/40608148 | PubMed |
| 40479553 | Targeting GABAergic Hypofunction Associated with Schizophrenia: Identification of α1β2γ2GABA-A Receptor Ligands with Neuroprotective and Antipsychotic Properties. | ACS Chem Neurosci | 2025 | https://conductscience.org/library/papers/40479553 | PubMed |
| 40375202 | Relationship between renal function and cognitive impairment in patients with stable schizophrenia: a multicenter cross-sectional study. | BMC Psychiatry | 2025 | https://conductscience.org/library/papers/40375202 | PubMed |
| 40361541 | Comparative Analysis of Polyphenolic Acids from Various Zea mays Parts in Ultrasound-Assisted Extraction. | Foods | 2025 | https://conductscience.org/library/papers/40361541 | PubMed |
| 40214957 | Revealing the Oxidative Stress-Related Molecular Characteristics and Potential Therapeutic Targets of Schizophrenia through Integrated Gene Expression Data Analysis. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40214957 | PubMed |
| 40137174 | Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease. | Metabolites | 2025 | https://conductscience.org/library/papers/40137174 | PubMed |
| 40060748 | Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/40060748 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979300
GET https://conductscience.org/api/papers/v1/36979300/references?page=2